Semarion, a University of Cambridge spin-out originating from the Cavendish Laboratory, has raised $3.8 million (£2.9 million) to advance its cell assay technology and support broader adoption across the pharmaceutical industry.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?